US Authorizes AstraZeneca Covid Treatment In Some Cases
Faizan Hashmi Published December 09, 2021 | 08:50 AM
Washington, Dec 9 (UrduPoint / Pakistan Point News - 9th Dec, 2021 ) :US health authorities on Wednesday authorized the use of synthetic antibodies developed by AstraZeneca to prevent Covid-19 infections in people who react badly to vaccines.
It was the first time the food and Drug Administration has given emergency authorization for such a purely preventative treatment.
The FDA warned the drug Evusheld is "not a substitute for vaccination in individuals for whom Covid-19 vaccination is recommended" and can only be authorized for people who have a weakened immune system or those who cannot be vaccinated for medical reasons, such a strong allergic reaction.
In those cases, the drug can be administered to people aged 12 and up.
Evusheld combines two types of synthetic antibodies (tixagevimab and cilgavimab), and is given as two intramuscular injections, one straight after the other. These antibodies help the immune system fight off the virus by targeting its spike protein, which allows it to enter cells and infect them.
The FDA said that the treatment "may be effective for pre-exposure prevention for six months.
" It cannot be administered to someone who is already infected with the virus, the FDA said, although AstraZeneca is testing it for such treatment.
Side effects may include an allergic reaction, bleeding from the injection site, headache, and fatigue.
The FDA authorization was based on a clinical trial carried out on unvaccinated people over 59 years of age, or with a chronic disease, or at high risk of infection.
The drug was given to 3,500 people while 1,700 received a placebo. The trial showed that the treatment cut the risk of developing Covid-19 by 77 percent.
Two cocktails of antibodies, made by Regeneron and Eli Lilly, are currently authorized for prevention of infection in the United States, but only in people who have been exposed to the virus shortly before, or who have a strong chance of being exposed, such as employees of retirement homes or prisons.
In addition to being immunocompromised or unvaccinated, these people must also be at high risk of developing a severe case of the disease.
Related Topics
Recent Stories
SIU arrests robbery gang targeting bank customers
Asia Cricket Week from April 28
PSA World C'ships in May
Food Safety Authority raids hospitals' canteen across KP
US Fed's favored inflation measure accelerates in March
Kenya flood death toll since March climbs to 70: govt
Rafiq-ul-Hujajj Committee to organize 2nd training session for pilgrims in Abbot ..
Defence Minister leads Pakistan's delegation to Kazakhstan SCO moot
PRCS Chairman, Moroccan envoy discuss humanitarian relations
50pc cut in subsidy of BRT service likely: CM’s aide
Russia striking Ukraine railways to 'paralyse' army cargo: Ukraine source
Cop, suspected outlaw injured in police encounter
More Stories From Miscellaneous
-
Modern Education Techniques: A pathway to achieve economic development
8 hours ago -
Kite Flying: From cultural festival to deadly sport
8 hours ago -
PDMA predicts gusty wind, rain with thunder, hails
3 days ago -
Iranian president Raisi given guard of honour at PM House
4 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
5 days ago -
Bahawalpur Adabi Sangat hosts memorable mushaira
5 days ago
-
Cattle farming vital to alleviate poverty in rural areas
5 days ago -
Pakistan: A land of tourism, archeological wonders
5 days ago -
Transforming education sector: from job hunters to job creators
7 days ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
11 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
12 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
12 days ago